Penerapan Seleksi Fitur pada Deteksi Coronavirus Disease 19 (COVID-19) berbasis Random Forest
DOI:
https://doi.org/10.32493/jtsi.v7i4.40755Kata Kunci:
Seleksi Fitur; Prediksi; COVID-19Abstrak
Data Mining menggunakan algoritma pembelajaran mesin (machine learning) dapat digunakan untuk membantu menganalisis data historis untuk memprediksi COVID-19. Dataset yang digunakan untuk memprediksi COVID-19 memiliki banyak fitur, namun fitur tersebut memiliki kemungkinan redundansi atau tidak relevan yang dapat menyebabkan penurunan kinerja pengklasifikasi. Penelitian ini mengusulkan model yang menerapkan pemilihan fitur (feature selection) untuk memilih fitur yang relevan dan dapat memberikan prediksi kinerja yang lebih baik untuk diagnosa/prediksi COVID-19. Beberapa teknik pemilihan fitur yang diusulkan adalah Sequential Forward Selection (SFS), Sequential Backward Selection (SBS), Sequential Forward Floating Selection ( SFFS), Sequential Forward Floating Selection (SBFS), Sequential Backward Floating Selection (SBFS), dan selectKBest. Algoritma klasifikasi yang digunakan untuk mengklasifikasikan adalah Random Forest. Model yang memberikan nilai kinerja terbaik adalah model yang menerapkan SFS dan SFFS sebagai seleksi fitur.
Referensi
Burhan, E., Susanto, A. D., Nasution, S. A., Ginanjar, E., Pitoyo, W., Susilo, A., & Dkk. (2020). Pedoman Tatalaksana COVID-19. In Pedoman Tatalaksana COVID-19 (3rd ed.).
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. Di. (2022). Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–., December 2020, 1–49.
Cennimo, D. J. (2024). Coronavirus Disease 2019 (COVID-19) (pp. 1–4). Medscape.
Gorunescu, F. (2011). Data mining: concepts and techniques. In Chemistry & https://doi.org/10.1007/978-3-642-19721-5
Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y., & Yan, Y. (2020). The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak – An Update on the Status. Military Medical Research, 7(11), 1–10. https://doi.org/10.1186/s40779-020-00240-0
Jiawei, H., Kamber, M., Han, J., Kamber, M., & Pei, J. (2012). Data Mining: Concepts and Techniques. In San Francisco, CA, itd: Morgan Kaufmann. https://doi.org/10.1016/B978-0-12-381479-1.00001-0
Liu, H., Jiang, H., & Zheng, R. (2016). The Hybrid Feature Selection Algorithm Based on Maximum Minimum Backward Selection Search Strategy for Liver Tissue Pathological Image Classification. Computational and Mathematical Methods in Medicine, 2016. https://doi.org/10.1155/2016/7369137
Mendez, C. M. (2020). Solidarity” Clinical Trial for COVID -19 Treatments. Brazilian Journal of Impleantology and Health Sciences, 1–6.
Nair, R., & Bhagat, A. (2019). Feature selection method to improve the accuracy of classification algorithm. International Journal of Innovative Technology and Exploring Engineering, 8(6), 124–127.
Oxford University. (2022). The RECOVERY Trial - two years on (pp. 1–2). Oxford University.
Sahin, A. R., Erdogan, A., Mutlu Agaoglu, P., Dineri, Y., Cakirci, A. Y., Senel, M. E., Okyay, R. A., & Tasdogan, A. M. (2020). 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. Eurasian Journal of Medicine and Oncology, 4(1), 1–7. https://doi.org/10.14744/ejmo.2020.12220
Sindi, S., Ningse, W. R. O., Sihombing, I. A., Ilmi R.H.Zer, F., & Hartama, D. (2020). Analisis Algoritma K-Medoids Clustering Dalam Pengelompokan Penyebaran Covid-19 Di Indonesia. Jti, 4(1), 166–173.
World Health Organization. (2020). Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases. In WHO - Interim guidance (pp. 1–7). World Health Organization. https://www.who.int/publications/i/item/WHO-2019-nCoV-lab-testing-2021.1-eng
Xue, B., Zhang, M., Browne, W. N., & Yao, X. (2016). A Survey on Evolutionary Computation Approaches to Feature Selection. IEEE Transactions on Evolutionary Computation, 20(4), 606–626. https://doi.org/10.1109/TEVC.2015.2504420
Yanti, E., Fridalni, N., & Harmawati. (2020). Mencegah Penularan Virus Corona. Journal Abdimas Saintika, 2, 7. https://jurnal.syedzasaintika.ac.id/index.php/abdimas/article/view/553/pdf
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Aries Saifudin, Endar Nirmala, Irpan Kusyadi
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Jurnal Teknologi Sistem Informasi dan Aplikasi have CC BY-NC or an equivalent license as the optimal license for the publication, distribution, use, and reuse of scholarly work.
In developing strategy and setting priorities, Jurnal Teknologi Sistem Informasi dan Aplikasi recognize that free access is better than priced access, libre access is better than free access, and libre under CC BY-NC or the equivalent is better than libre under more restrictive open licenses. We should achieve what we can when we can. We should not delay achieving free in order to achieve libre, and we should not stop with free when we can achieve libre.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) License
YOU ARE FREE TO:
- Share - copy and redistribute the material in any medium or format
- Adapt - remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms